(Q39827802)

15 September 2017

Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects (English)

1 reference

15 September 2017

1 reference

Gregoire SL

1

1 reference

15 September 2017

Grasela TH Jr

2

1 reference

15 September 2017

Freer JP

3

1 reference

15 September 2017

Tack KJ

4

1 reference

15 September 2017

Schentag JJ

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

31

1 reference

15 September 2017

3

1 reference

15 September 2017

375-378

1 reference

In vitro and in vivo activity of DL-8280, a new oxazine derivative

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Theophylline A “State of the Art” Review

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Enoxacin raises plasma theophylline concentrations

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Convulsions and hyperglycaemia associated with nalidixic acid

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174735

Alteration of Theophylline Clearance and Half-life by Cimetidine in Normal Volunteers

17 June 2018

1 reference

12 December 2020

[Neurologic side effects of quinolones]

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of ofloxacin

1 reference

12 December 2020

Effect of rifampicin administration on theophylline pharmacokinetics in humans

1 reference

12 December 2020

Pharmacokinetics of ofloxacin and theophylline alone and in combination

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.31.3.375

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

3472488

1 reference